Colonization with multidrug-resistant bacteria among children hospitalized abroad-a study from Finland.

IF 5.5 2区 医学 Q1 INFECTIOUS DISEASES
Hilda Mäkinen, Mikael Kajova, Tamim Khawaja, Anu Kantele
{"title":"Colonization with multidrug-resistant bacteria among children hospitalized abroad-a study from Finland.","authors":"Hilda Mäkinen, Mikael Kajova, Tamim Khawaja, Anu Kantele","doi":"10.1093/jtm/taag003","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>International travel contributes to the global spread of antimicrobial resistance: a substantial proportion of travellers visiting low- and middle-income countries (LMICs) are colonized by multidrug-resistant organisms (MDRO), with those hospitalized abroad at a particular risk. In some, colonization leads to symptomatic MDRO infection. Although children are a recognized risk group, research on travel-acquired MDRO among paediatric patients remains limited.</p><p><strong>Methods: </strong>At our hospital, patients hospitalized abroad within the past 12 months are routinely screened for MDROs upon admission. To assess MDRO colonization among children following hospitalization abroad, we analysed MDRO screening data from paediatric patients at HUS Helsinki University Hospital 2010-2024, and explored associated risk factors.</p><p><strong>Results: </strong>Among the 459 paediatric patients screened after hospitalization abroad, 158 (34.4%) were colonized with MDROs. The most common MDROs were extended-spectrum β-lactamase-producing Enterobacterales (29.0%) and methicillin-resistant Staphylococcus aureus (7.6%). Carbapenemase-producing Enterobacterales were identified in 14 children (3.1%).Multivariable analysis identified antibiotic use (P = 0.002), travel type (P < 0.001) and income level of the hospitalization country (P < 0.001) as independent risk factors for colonization. The income level gradient was substantial: 87.5% (21/24) of children hospitalized in low-income countries, 68.1% (49/72) in lower-middle-income, 46.6% (55/118) in upper-middle-income and 13.5% (33/245) in high-income countries were colonized with MDROs. Clinical MDRO infection was recorded in five of the 158 (3.2%) MDRO carriers.</p><p><strong>Conclusions: </strong>MDRO colonization is common among children hospitalized abroad, showing a clear gradient increase with decreasing country income level. Screening and infection control measures are warranted after recent care abroad. Particular focus should be placed on those hospitalized in LMICs, and those with additional risk factors such as visiting friends and relatives travel, foreign residence, or recent antibiotic use.</p>","PeriodicalId":17407,"journal":{"name":"Journal of travel medicine","volume":" ","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13042226/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of travel medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jtm/taag003","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: International travel contributes to the global spread of antimicrobial resistance: a substantial proportion of travellers visiting low- and middle-income countries (LMICs) are colonized by multidrug-resistant organisms (MDRO), with those hospitalized abroad at a particular risk. In some, colonization leads to symptomatic MDRO infection. Although children are a recognized risk group, research on travel-acquired MDRO among paediatric patients remains limited.

Methods: At our hospital, patients hospitalized abroad within the past 12 months are routinely screened for MDROs upon admission. To assess MDRO colonization among children following hospitalization abroad, we analysed MDRO screening data from paediatric patients at HUS Helsinki University Hospital 2010-2024, and explored associated risk factors.

Results: Among the 459 paediatric patients screened after hospitalization abroad, 158 (34.4%) were colonized with MDROs. The most common MDROs were extended-spectrum β-lactamase-producing Enterobacterales (29.0%) and methicillin-resistant Staphylococcus aureus (7.6%). Carbapenemase-producing Enterobacterales were identified in 14 children (3.1%).Multivariable analysis identified antibiotic use (P = 0.002), travel type (P < 0.001) and income level of the hospitalization country (P < 0.001) as independent risk factors for colonization. The income level gradient was substantial: 87.5% (21/24) of children hospitalized in low-income countries, 68.1% (49/72) in lower-middle-income, 46.6% (55/118) in upper-middle-income and 13.5% (33/245) in high-income countries were colonized with MDROs. Clinical MDRO infection was recorded in five of the 158 (3.2%) MDRO carriers.

Conclusions: MDRO colonization is common among children hospitalized abroad, showing a clear gradient increase with decreasing country income level. Screening and infection control measures are warranted after recent care abroad. Particular focus should be placed on those hospitalized in LMICs, and those with additional risk factors such as visiting friends and relatives travel, foreign residence, or recent antibiotic use.

国外住院儿童中耐多药细菌的定植——来自芬兰的研究。
背景:国际旅行促进了抗菌素耐药性(AMR)的全球传播:访问低收入和中等收入国家(LMICs)的旅行者中有相当大一部分被耐多药微生物(MDRO)定居,在国外住院的旅行者面临特别的风险。在某些情况下,定植导致有症状的MDRO感染。虽然儿童是公认的风险群体,但对儿童患者中旅行获得性MDRO的研究仍然有限。方法:我院对过去12个月内在国外住院的患者在入院时进行MDROs常规筛查。为了评估国外住院儿童的MDRO定植,我们分析了2010-2024年赫尔辛基大学HUS医院儿科患者的MDRO筛查数据,并探讨了相关的危险因素。结果:459例境外住院患儿中,有158例(34.4%)存在MDROs定植。最常见的mdro是广谱产β-内酰胺酶肠杆菌(ESBL-PE)(29.0%)和耐甲氧西林金黄色葡萄球菌(MRSA)(7.6%)。产碳青霉烯酶肠杆菌(CPE) 14例(3.1%)。结论:MDRO定植在国外住院儿童中很常见,并随着国家收入水平的降低呈现明显的梯度增加。最近在国外接受治疗后,有必要采取筛查和感染控制措施。应特别关注中低收入国家的住院患者,以及那些有额外风险因素的患者,如VFR(探亲访友)旅行、在国外居住或最近使用抗生素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of travel medicine
Journal of travel medicine 医学-医学:内科
CiteScore
20.90
自引率
5.10%
发文量
143
审稿时长
6-12 weeks
期刊介绍: The Journal of Travel Medicine is a publication that focuses on travel medicine and its intersection with other disciplines. It publishes cutting-edge research, consensus papers, policy papers, and expert reviews. The journal is affiliated with the Asia Pacific Travel Health Society. The journal's main areas of interest include the prevention and management of travel-associated infections, non-communicable diseases, vaccines, malaria prevention and treatment, multi-drug resistant pathogens, and surveillance on all individuals crossing international borders. The Journal of Travel Medicine is indexed in multiple major indexing services, including Adis International Ltd., CABI, EBSCOhost, Elsevier BV, Gale, Journal Watch Infectious Diseases (Online), MetaPress, National Library of Medicine, OCLC, Ovid, ProQuest, Thomson Reuters, and the U.S. National Library of Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书